Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Alexander Melamud (NPI 1669573788)

Field	Value
Entity Type	Individual
Organization	Alexander Melamud
Address	8270 Willow Oaks Corporate Dr Fl 6
City	Fairfax
State	VA
ZIP	22031
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	September 25, 2006

Payer Source	Total Paid
Medicare	$4.2M
Medicaid	$0

Key Findings

This provider is clinically focused on retina care and intravitreal biologic therapy: the top revenue-driving codes are J0178 (aflibercept), J2777 (faricimab), and J3590 (unclassified biologics), and procedure codes like 67028 (intravitreal injection) also appear in the top line items. The CPT mix—high-volume anti-VEGF and other intravitreal drug codes alongside retina imaging and injection procedure codes—is consistent with a retina specialist whose practice is organized around frequent in-office injections and diagnostic retinal imaging.

Revenue concentration is high: total Medicare revenue is $4.2M and the precomputed top 3 Medicare codes by revenue account for 69.3% of this provider's total Medicare revenue. Reliance on a small set of drug-administration codes (J0178, J2777, J3590) means reimbursement shifts or changes in drug utilization would materially affect overall Medicare revenue.

J0178 is the single largest Medicare revenue contributor at $1.8M (43.4% of Medicare revenue); it ranks #260 of 3204 providers nationally and is reported as 92th percentile with a label of "typical, unremarkable volume for this code." This indicates strong absolute revenue concentration in aflibercept injections while the dataset characterizes the provider's utilization of J0178 as within the expected peer distribution.

J2777 ($609K, 14.5% of Medicare revenue) and J3590 ($481.2K, 11.4% of Medicare revenue) complete the three-code concentration; both rank in mid-to-upper national percentiles (J2777 at the 76th and J3590 at the 71th) and are described as "typical, unremarkable" in volume relative to peers. The presence of J3590 with a high reported average paid/claim ($2382) signals use of high-cost or unclassified biologic products that materially contribute to revenue despite lower claim counts.

Beyond drug administration, clinical throughput is high for office examinations and retinal imaging: 92014 (established comprehensive eye exam) generated $357.3K (8.5% of Medicare revenue) and is labeled an "extreme outlier, far above typical national volume," while 92134 (retinal imaging) produced $124.2K (3.0%) and is a "extreme outlier, far above typical national volume." These extreme-outlier designations suggest unusually high exam and imaging volume relative to national peers, supporting the view of a high-touch retina practice with frequent follow-up and monitoring.

Procedure-level injection activity is notable: 67028 (intravitreal injection as an isolated procedure) accounts for $219.2K (5.2% of Medicare revenue) and is labeled "notably above typical national volume." Together with the drug codes, this indicates both the administration and the drug costs are significant revenue sources rather than one or the other alone.

Competitive standing across Medicare for high-revenue items is mixed: the provider is nationally prominent on some retina diagnostics (92014 at the 100th percentile and 92134 at the 99th percentile, both "extreme outlier") while for major drug codes the provider sits at solid but not dominant percentiles (J0178 92th, J2777 76th, J3590 71th) with those drug codes characterized as "typical, unremarkable volume." This pattern indicates the provider is a high-volume diagnostic/exam outlier but a more typical peer in per-drug administration volume.

Payer mix is effectively single-payer in scope: the profile shows total Medicare revenue of $4.2M and no Medicaid billing on file ("none below"), so the provider operates without a Medicaid footprint in this dataset. That concentration makes Medicare reimbursement trends and drug-pricing/coverage decisions especially consequential to the practice's financial performance.

Tenure: the NPI was enumerated on 2006-09-25 (~20 years ago), indicating long-established billing activity and a sustained presence in the Medicare program; the combination of long tenure and the observed high exam/imaging volumes supports a mature retina practice with established referral and follow-up workflows.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

21 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,660	$690	$1.8M
J2777	Injection, faricimab‑svoa, 0.1 mg	21,000	$30	$609K
J3590	Unclassified biologics	200	$2,380	$481.2K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	3,650	$100	$357.3K
J2778	Injection, ranibizumab, 0.1 mg	1,890	$190	$353.4K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,240	$100	$219.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,650	$30	$124.2K
J3490	Unclassified drugs	40	$1,770	$67.1K
Q5128	Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg	180	$210	$37.5K
92202	The provider performs an extended ophthalmoscopy, typically with an indirect ophthalmoscope which utilizes a bright light and a hand–held indirect lens rather than the common hand–held one–piece…	2,380	$10	$31K

Showing 1–10 of 21

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 21 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Virginia Distribution

Alexander Melamud — 4 of 21 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Virginia

Full comparison — all codes billed, vs. state median

21 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	18	80	1,400	$690	$1.1M
J2777	19	60	13,200	$30	$517.1K
J2778	6	40	560	$180	$171.5K
J3590	1	20	40	$2,290	$126K
67028	12	90	1,000	$90	$107.1K
J2781	16	20	560	$120	$86.6K
Q5128	5	10	190	$220	$70.7K
92014	5	870	170	$80	$32.8K
99214	8,742	12,890	140	$80	$21K
J3490	76	110	60	$280	$20.5K

Showing 1–10 of 21

Related Providers

Other providers that share a Tax Identification Number (TIN) with Alexander Melamud, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
The Retina Group Of Washington, PLLC	MD	Ophthalmology Physician	$0	$19.5M
Virginia Oncology Associates	VA	Hematology & Oncology Physician	$0	$6.2M
Rohit Lakhanpal	MD	Retina Specialist (Ophthalmology) Physician	$6.1M	$0
Gordon Byrnes	VA	Retina Specialist (Ophthalmology) Physician	$4.9M	$0
Daniel Berinstein	MD	Retina Specialist (Ophthalmology) Physician	$4.3M	$0
Michael Lai	MD	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Jordana Fein	VA	Retina Specialist (Ophthalmology) Physician	$4.2M	$0
Eric Weichel	MD	Ophthalmology Physician	$4.1M	$0
Gayatri Reilly	MD	Retina Specialist (Ophthalmology) Physician	$4.1M	$0
Sundeep Kasi	VA	Retina Specialist (Ophthalmology) Physician	$4.1M	$0

Nearby Providers

Other providers in the same ZIP code as Alexander Melamud, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
A Kind & Caring Home Care,llc	VA	Home Health Agency	$0	$35.7M
Alpha Home Care Services LLC	VA	Home Health Agency	$0	$32.2M
Community Living Alternatives, Corp.	VA	Intellectual and/or Developmental Disabilities Community Based Residential Treatment Facility	$0	$31M
Gateway Healthcare Services LLC	VA	Home Health Agency	$0	$22.1M
Praise Home Health Services, Inc	VA	Home Health Agency	$0	$22M
Grace Home Healthcare, LLC	VA	Home Health Agency	$0	$20.5M
Aloha Home Healthcare Services,llc	VA	Home Health Agency	$0	$13.1M
Precious Care At Home Services Inc	VA	Home Health Aide	$0	$12.5M
Inova Health Care Services	VA	Clinical Medical Laboratory	$5.4M	$6.8M
Pediatric Specialists Of Virginia, LLC	VA	Pediatrics Physician	$0	$11.3M

Alexander Melamud — Billing Profile & Reimbursement Data

Sign up for Alexander Melamud — Billing Profile & Reimbursement Data policy alerts

Alexander Melamud — Billing Profile & Reimbursement Data

Sign up for Alexander Melamud — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References